Akèy › Leksemi mieloïd egi › Illinois › Cicero
Etid klinik pou Leksemi mieloïd egi nan Cicero, IL
11 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Cicero (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Loyola University Medical Center, Maywood · 5 mi lwen
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
- ak 2 plis
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Loyola University Medical Center, Maywood · 5 mi lwen
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- Loyola University Medical Center, Maywood · 5 mi lwen
- Advocate Children's Hospital-Oak Lawn, Oak Lawn · 9 mi lwen
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- Loyola University Medical Center, Maywood · 5 mi lwen
- Advocate Children's Hospital-Oak Lawn, Oak Lawn · 9 mi lwen
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- Loyola University Medical Center, Maywood · 5 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Loyola University Medical Center, Maywood · 5 mi lwen
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ap rekriteFaz 1
- Loyola University Medical Center, Maywood · 5 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Baldwin Park, CA40 etid
- Seattle, WA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA30 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan Cicero
- Kansè Poumon ki pa ti selil24 etid
- Kansè poumon17 etid
- Kansè pwostat14 etid
- Kansè (tout kalite)13 etid
- Kansè nan tete11 etid
- Kansè kolorektal10 etid
- Kansè vejik8 etid
- Kansè Metastatik7 etid
- Melanom7 etid
- Maladi kadyovaskilè7 etid
- Limfòm Burkitt6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.